Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice

GLIA

Volumn 62, Issue 8, 2014, Pages 1227-1240

  Cekanaviciute, Egle ^a,b   Fathali, Nancy ^a   Doyle, Kristian P ^a   Williams, Aaron M ^a   Han, Jullet ^a   Buckwalter, Marion S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Astrocytes; Cytokines; Immunity; Inflammation; Ischemia

Indexed keywords

CD68 ANTIGEN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TRANSFORMING GROWTH FACTOR BETA; CD11B ANTIGEN; TGFB1 PROTEIN, MOUSE; THROMBOSPONDIN-1, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD VESSEL OCCLUSION; BRAIN FUNCTION; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISTAL MIDDLE CEREBRAL OCCLUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INNATE IMMUNITY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR CORTEX; MOTOR PERFORMANCE; MOUSE; MULTIPLEX LUMINEX ASSAY; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCAR FORMATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BRAIN CORTEX; CEREBRAL ARTERY DISEASE; DISEASE MODEL; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; MACROPHAGE; METABOLISM; MONOCYTE; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; ASTROCYTES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MICE, TRANSGENIC; MICROGLIA; MONOCYTES; MOTOR ACTIVITY; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION; STROKE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84902345621     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22675     Document Type: Article

References (72)

1. Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFbeta activation. J Cell Sci 116:217-224.
2. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, Albers GW, Steinman L, Steinberg GK. 2011. Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci USA 108:13287-13292.
3. Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922-7930.
4. Barreto G, White RE, Ouyang Y, Xu L, Giffard RG. 2011. Astrocytes: Targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 11:164-173.
5. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR. 2005. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 202:145-156.
6. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030-1037.
7. Brown GC. 2010. Nitric oxide and neuronal death. Nitric Oxide 23:153-165.
8. Buckwalter M, Wyss-Coray T. 2004. Modelling neuroinflammatory phenotypes in vivo. J Neuroinflammation 1:10.
9. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23:297-308.
10. Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL. 2005. Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: An angiogenic control switch. Am J Pathol 166:1883-1894.
11. Chen Y, Swanson RA. 2003. Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149.
12. Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G, Carmichael ST. 2011. AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci 31:3766-3775.
13. Colak G, Filiano AJ, Johnson GV. 2011. The application of permanent middle cerebral artery ligation in the mouse. J Vis Exp 53.
14. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SMF, Lawler J, Hynes RO, Boivin GP, Bouck N. 1998. Thrombospondin-1 is a major activator of TGF-b1 in vivo. Cell 93:1159-1170.
15. Crowe MJ, Doetschman T, Greenhalgh DG. 2000. Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 115:3-11.
16. Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF, Vexler ZS. 2007. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 100:893-904.
17. Dhandapani KM, Brann DW. 2003. Transforming growth factor-beta: A neuroprotective factor in cerebral ischemia. Cell Biochem Biophys 39:13-22.
18. Dheen ST, Kaur C, Ling EA. 2007. Microglial activation and its implications in the brain diseases. Curr Med Chem 14:1189-1197.
19. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS. 2010. TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflamm 7:62.
20. Doyle KP, Fathali N, Siddiqui MR, Buckwalter MS. 2012. Distal hypoxic stroke: A new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. J Neurosci Methods 207:31-40.
21. Dvoriantchikova G, Barakat D, Brambilla R, Agudelo C, Hernandez E, Bethea JR, Shestopalov VI, Ivanov D. 2009. Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur J Neurosci 30:175-185.
22. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2, and PAF. J Clin Invest 101:890-898.
23. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. 1993. TGF-b1 is an organizer of responses to neurodegeneration. J Cell Biochem 53:314-322.
24. Florian C, Vecsey CG, Halassa MM, Haydon PG, Abel T. 2011. Astrocyte-derived adenosine and A1 receptor activity contribute to sleep loss-induced deficits in hippocampal synaptic plasticity and memory in mice. J Neurosci 31:6956-6962.
25. Frugier T, Koishi K, Matthaei KI, McLennan IS. 2005. Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TbetaRII). Genesis 42:1-5.
26. Gao Z, Zhu Q, Zhang Y, Zhao Y, Cai L, Shields CB, Cai J. 2013. Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury. Mol Neurobiol 48:690-701.
27. Garcia JH, Wagner S, Liu KF, Hu XJ. 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26:627-634; discussion 635.
28. Glabinski AR, Balasingam V, Tani M, Kunkel SL, Strieter RM, Yong VW, Ransohoff RM. 1996. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 156:4363-4368.
29. Halassa MM, Florian C, Fellin T, Munoz JR, Lee SY, Abel T, Haydon PG, Frank MG. 2009. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61:213-219.
30. Heiss WD. 2012. The ischemic penumbra: How does tissue injury evolve? Ann N Y Acad Sci 1268:26-34.
31. Iadecola C, Anrather J. 2011. The immunology of stroke: From mechanisms to translation. Nat Med 17:796-808.
32. Ikeda H, Miyatake M, Koshikawa N, Ochiai K, Yamada K, Kiss A, Donlin MJ, Panneton WM, Churchill JD, Green M, Siddiqui AM, Leinweber AL, Crews NR, Ezerskiy LA, Rendell VR, Belcheva MM, Coscia CJ. 2010. Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation. J Biol Chem 285:38415-38427.
33. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
34. Krohn K, Rozovsky I, Wals P, Teter B, Anderson CP, Finch CE. 1999. Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. J Neurochem 72:1353-1361.
35. Krupinski J, Kumar P, Kumar S, Kaluza J. 1996. Increased expression of TGF-b1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857.
36. Lanz TV, Ding Z, Ho PP, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L. 2010. Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 120:2782-2794.
37. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, Yabe T, Moors L, Fotheringham A, Davies I, Carmeliet P, Schwartz JP, Pekna M, Kubista M, Blomstrand F, Maragakis N, Nilsson M, Pekny M. 2008. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28:468-481.
38. Lin HY, Yang LT. 2013. Differential response of epithelial stem cell populations in hair follicles to TGF-beta signaling. Dev Biol 373:394-406.
39. Logan A, Berry M, Gonzalez A, Frautschy S, Sporn M, Baird A. 1994. Effects of transforming growth factor beta 1 on scar production in the injured central nervous systems of the rat. Eur J Neurosci 6:355-363.
40. Manaenko A, Fathali N, Khatibi NH, Lekic T, Hasegawa Y, Martin R, Tang J, Zhang JH. 2011. Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury. Neurochem Int 58:542-548.
41. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686.
42. Massagué J, Wotton D. 2000. Transcriptional control by the TGF-b/Smad signaling system. EMBO J 19:1745-1754.
43. Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. 2012. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol 188:29-36.
44. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. 2002. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157:493-507.
45. Ortiz-Masia D, Diez I, Calatayud S, Hernandez C, Cosin-Roger J, Hinojosa J, Esplugues JV, Barrachina MD. 2012. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process. PLoS One 7:e48535.
46. Pang L, Ye W, Che XM, Roessler BJ, Betz AL, Yang GY. 2001. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-1 expression. Stroke J Cereb Circ 32:544-552.
47. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, Takano H, Moss SJ, McCarthy K, Haydon PG. 2005. Astrocytic purinergic signaling coordinates synaptic networks. Science 310:113-116.
48. Pineau I, Sun L, Bastien D, Lacroix S. 2010. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav Immun 24:540-553.
49. Pratt BM, McPherson JM. 1997. TGF-beta in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev 8:267-292.
50. Rani R, Smulian AG, Greaves DR, Hogan SP, Herbert DR. 2011. TGF-beta limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol 41:2000-2009.
51. Reilly JF, Maher PA, Kumari VG. 1998. Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. Glia 22:202-210.
52. Romao LF, Sousa Vde O, Neto VM, Gomes FC. 2008. Glutamate activates GFAP gene promoter from cultured astrocytes through TGF-beta1 pathways. J Neurochem 106:746-756.
53. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A. 1999. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 19:1345-1353.
54. Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, Degen JL, Margolis RU, Akassoglou K. 2010. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J Neurosci 30:5843-5854.
55. Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K. 2010. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol 184:7207-7218.
56. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
57. Smith GM, Hale JH. 1997. Macrophage/microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 17:9624-9633.
58. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119:7-35.
59. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP. 2002. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932:110-119.
60. Vivien D, Ali C. 2006. Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev 17:121-128.
61. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV. 2009. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29:11511-11522.
62. Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y, Sofroniew MV. 2013. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33:12870-12886.
63. Woo MS, Wang X, Faustino JV, Derugin N, Wendland MF, Zhou P, Iadecola C, Vexler ZS. 2012. Genetic deletion of CD36 enhances injury after acute neonatal stroke. Ann Neurol 72:961-970.
64. Wyss-Coray T, Borrow P, Brooker MJ, Mucke L. 1997. Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 77:45-50.
65. Yamashita K, Gerken U, Vogel P, Hossmann K, Wiessner C. 1999. Biphasic expression of TGF-beta1 mRNA in the rat brain following permanent occlusion of the middle cerebral artery. Brain Res 836:139-145.
66. Yonezawa T, Hattori S, Inagaki J, Kurosaki M, Takigawa T, Hirohata S, Miyoshi T, Ninomiya Y. 2010. Type IV collagen induces expression of thrombospondin-1 that is mediated by integrin alpha1beta1 in astrocytes. Glia 58:755-767.
67. Yoshioka N, Kimura-Kuroda J, Saito T, Kawamura K, Hisanaga S, Kawano H. 2011. Small molecule inhibitor of type I transforming growth factor-beta receptor kinase ameliorates the inhibitory milieu in injured brain and promotes regeneration of nigrostriatal dopaminergic axons. J Neurosci Res 89:381-393.
68. Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. 2012. Genomic analysis of reactive astrogliosis. J Neurosci 32:6391-6410.
69. Zhang YE. 2009. Non-Smad pathways in TGF-beta signaling. Cell Res 19:128-139.
70. Zhao H, Sapolsky RM, Steinberg GK. 2006. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 34:249-270.
71. Zhu Y, Culmsee C, Klumpp S, Krieglstein J. 2004. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1, 2 signaling pathways. Neuroscience 123:897-906.
72. Zhu Y, Yang G-Y, Ahlemeyer B, Pang L, Che X-M, Culmsee C, Klumpp S, Krieglstein J. 2002. Transforming growth factor-b1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22:3898-3909.